Feasibility and Safety of Outpatient Bexxar® Therapy (Tositumomab and Iodine I 131 Tositumomab) for Non-Hodgkin's Lymphoma Based on Radiation Doses to Family Members-Reference-Cited by-同舟云学术

Feasibility and Safety of Outpatient Bexxar® Therapy (Tositumomab and Iodine I 131 Tositumomab) for Non-Hodgkin's Lymphoma Based on Radiation Doses to Family Members

Published:2001-12 Issue:3 Volume:2 Page:164-172
ISSN:1526-9655
Container-title:Clinical Lymphoma
language:en
Short-container-title:Clinical Lymphoma

Author:

Rutar Frank J.,Augustine Samuel C.,Kaminski Mark S.,Wahl Richard L.,Siegel Jeffry A.,Colcher David

Publisher

Elsevier BV

Subject

Cancer Research

Reference31 articles.

1. Treatment of non-Hodgkin's lymphoma;Armitage;N Engl J Med,1993

2. Natural history of and therapy for the indolent non-Hodgkin's lymphomas;Horning;Semin Oncol,1993

3. Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience;Kaminski;Blood,2000

4. High-dose therapy and transplantation in non- Hodgkin's lymphoma;Morrison;Semin Oncol,1999

5. Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation;Appelbaum;J Clin Oncol,1987

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaches to Reducing Normal Tissue Radiation from Radiolabeled Antibodies;Pharmaceuticals;2024-04-16

2. Radionuclide Leptomeningeal Metastasis Therapy Trials;Radiopharmaceuticals in the Management of Leptomeningeal Metastasis;2022

3. Radiation Protection in Medicine (Medical Health Physics);Radiation Protection in Medical Imaging and Radiation Oncology;2015-12-10

4. Cancer Cell Radiobiological Studies Using In-House-Developed α-Particle Irradiator;Cancer Biotherapy and Radiopharmaceuticals;2015-11

5. Immunotherapeutic approaches for cancer therapy: An updated review;Artificial Cells, Nanomedicine, and Biotechnology;2015-03-24